Novel Derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with Improved Fluorescent and σ Receptors Binding Properties
摘要:
Despite the promising potentials of sigma(2) receptors in cancer therapy and diagnosis, there are still ambiguities related to the nature and physiological role of the a, protein. With the aim of providing potent and reliable tools to be used in sigma(2) receptor research, we developed a novel series of fluorescent sigma(2) ligands on the basis of our previous work, where high-affinity sigma(2) ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl]piperazine (1, PB28) was used as the pharmacophore. Compared to the previous compounds, these novel ligands displayed improved fluorescence and a, binding properties, were sigma(2)-specifically taken up by breast tumor cells, and were successfully employed in confocal microscopy. Compound 14, which was the best compromise between pharmacological and fluorescent properties, was successfully employed in flow cytometry, demonstrating its potential to be used as a tool in nonradioactive binding assays for studying the affinity of putative sigma(2) receptor ligands.
Novel Derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with Improved Fluorescent and σ Receptors Binding Properties
摘要:
Despite the promising potentials of sigma(2) receptors in cancer therapy and diagnosis, there are still ambiguities related to the nature and physiological role of the a, protein. With the aim of providing potent and reliable tools to be used in sigma(2) receptor research, we developed a novel series of fluorescent sigma(2) ligands on the basis of our previous work, where high-affinity sigma(2) ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl]piperazine (1, PB28) was used as the pharmacophore. Compared to the previous compounds, these novel ligands displayed improved fluorescence and a, binding properties, were sigma(2)-specifically taken up by breast tumor cells, and were successfully employed in confocal microscopy. Compound 14, which was the best compromise between pharmacological and fluorescent properties, was successfully employed in flow cytometry, demonstrating its potential to be used as a tool in nonradioactive binding assays for studying the affinity of putative sigma(2) receptor ligands.
Novel and Selective Fluorescent σ<sub>2</sub>-Receptor Ligand with a 3,4-Dihydroisoquinolin-1-one Scaffold: A Tool to Study σ<sub>2</sub>Receptors in Living Cells
作者:Mauro Niso、Chiara Riganti、Maria Laura Pati、Dario Ghigo、Francesco Berardi、Carmen Abate
DOI:10.1002/cbic.201402712
日期:2015.5.4
Lighting up the competition: A fluorescentligand that is selective for the sigma‐2 receptor was developed and validated as an alternative to non‐selective sigma receptor probes. The novel probe was found to be competitive with prior non‐fluorescent probes and could serve as a powerful new tool for σ2 receptor research.
Development of sigma-1 (σ 1 ) receptor fluorescent ligands as versatile tools to study σ 1 receptors
作者:Carmen Abate、Chiara Riganti、Maria Laura Pati、Dario Ghigo、Francesco Berardi、Timur Mavlyutov、Lian-Wang Guo、Arnold Ruoho
DOI:10.1016/j.ejmech.2015.12.014
日期:2016.1
Despite their controversial physiology, sigma-1 (sigma(1)) receptors are intriguing targets for the development of therapeutic agents for central nervous system diseases. With the aim of providing versatile pharmacological tools to study sigma(1) receptors, we developed three sigma(1) fluorescent tracers by functionalizing three well characterized sigma(1) ligands with a fluorescent tag. A good compromise between sigma(1) binding affinity and fluorescent properties was reached, and the sigma(1) specific targeting of the novel tracers was demonstrated by confocal microscopy and flow cytometry. These novel ligands were also successfully used in competition binding studies by flow cytometry, showing their utility in nonradioactive binding assays as an alternative strategy to the more classical radioligand binding assays. To the best of our knowledge these are the first sigma(1) fluorescent ligands to be developed and successfully employed in living cells, representing promising tools to strengthen ai receptors related studies. (C) 2015 Elsevier Masson SAS. All rights reserved.